Zacks Company Profile for Myomo, Inc. (MYO : AMEX) |
|
|
|
Company Description |
Myomo, Inc. is a commercial stage medical robotics company. It offers expanded mobility which suffering from neurological disorders and upper limb paralysis. The company develops and markets the MyoPro(R) product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals. Myomo, Inc. is headquartered in Cambridge,Massachusetts.
Number of Employees: 93 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $2.55 |
Daily Weekly Monthly
 |
20 Day Moving Average: 32,417 shares |
Shares Outstanding: 6.88 (millions) |
Market Capitalization: $17.53 (millions) |
Beta: 1.06 |
52 Week High: $14.35 |
52 Week Low: $2.28 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
-31.27% |
-24.97% |
12 Week |
-65.63% |
-62.86% |
Year To Date |
-62.75% |
-55.87% |
|
|
|
|
|
Address & Contact Information |
Street Address |
Phone / Fax |
Email Address |
Web URL |
137 Portland St. 4th Floor - Boston,MA 02114 USA |
ph: 617-996-9058 fax: - |
ir@myomo.com |
http://www.myomo.com |
|
|
|
General Corporate Information |
Officers
Paul R. Gudonis - Chief Executive Officer and Chairman
David A. Henry - Chief Financial Officer
Amy Knapp - Director
Thomas A. Crowley, Jr. - Director
Thomas F. Kirk - Director
|
|
Peer Information
Myomo, Inc. (BJCT)
Myomo, Inc. (CADMQ)
Myomo, Inc. (APNO)
Myomo, Inc. (UPDC)
Myomo, Inc. (IMTIQ)
Myomo, Inc. (CYGN)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 62857J201
SIC: 3842
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/08/22
|
|
Share - Related Items
Shares Outstanding: 6.88
Most Recent Split Date: 1.00 (0.03:1)
Beta: 1.06
Market Capitalization: $17.53 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 0.00% |
Current Fiscal Quarter EPS Consensus Estimate: $-0.36 |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $-1.43 |
Payout Ratio: |
Number of Estimates in the Fiscal Year Consensus: 2.00 |
Change In Payout Ratio: |
Estmated Long-Term EPS Growth Rate: 25.00% |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: 08/08/22 |
|
|
|
|